| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3198559 | Journal of Allergy and Clinical Immunology | 2012 | 11 Pages |
Abstract
The inhibitory capabilities of TGA reported here suggest that FDs might be used a platform for developing treatments for asthma.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sarah K. PhD, Dayanjan S. PhD, Anthony BS, Jamie PhD, Zhiguo PhD, Suzanne PhD, Charles PhD, Daniel H. PhD, Christopher L. PhD, MBA,